Clinical Trials Logo

Remission clinical trials

View clinical trials related to Remission.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06199817 Completed - Schizophrenia Clinical Trials

The Effect Of Multiple Occupational Therapies On Functional Remission And Subjective Recovery For Schizophrenia

Start date: June 1, 2016
Phase: N/A
Study type: Interventional

Objective: This study aimed to evaluate the effect of multiple occupational therapies on functional remission and subjective recovery of individuals with schizophrenic disorder. Methods: 26 people with schizophrenic disorder were divided into two groups using a random number table. The intervention group participated in routine community mental health center services and a total of 24 sessions of occupational therapies three times a week, while the control group participated in routine community mental health center services.

NCT ID: NCT05459987 Completed - Clinical trials for Coronary Heart Disease

Feasibility of Prediabetes Remission in Adults With Coronary Heart Disease

DIABEPIC1
Start date: March 15, 2022
Phase: N/A
Study type: Interventional

To evaluate the feasibility of a 6-month multidisciplinary program to reverse prediabetes in adults with coronary heart disease using the Mediterranean diet, intermittent fasting and exercise.

NCT ID: NCT05358158 Completed - Pain Clinical Trials

Chest dRain rEmoval intrAoperatively afTer thoracOscopic Wedge Resection

CREATOR
Start date: May 4, 2022
Phase: N/A
Study type: Interventional

Chest drain is used routinely after lung surgery. Despite preliminary studies demonstrate the feasibility and safety of intraoperative chest drain removal, these are either retrospective or mainly concerning benign disease. Hypothesis: Participants treated without post-operative chest tube after thoracoscopic wedge resection have less pain, reduced opioid usage without increasing postoperative complications than participants treated with standard post-operative chest tube, and could possibly be discharged earlier.

NCT ID: NCT03831750 Completed - Clinical trials for Inflammatory Bowel Diseases

Assessing the Effectiveness of a Stress Reduction Intervention in Inflammatory Bowel Disease (IBD)

Start date: February 22, 2019
Phase: N/A
Study type: Interventional

The investigators have designed a guided, online, tri-component, stress reduction intervention for participants with inflammatory bowel diseases.

NCT ID: NCT03574948 Completed - Ulcerative Colitis Clinical Trials

5-HTP in Patients With IBD in Clinical and Biologic Remission:Effect on Fatigue Scores

TRP-IBD
Start date: December 6, 2018
Phase: Phase 2
Study type: Interventional

This placebo cross-over trial aims to study the effect of the oral intake of an essential amino-acid 5-OH tryptophan, the precursor of serotonin, on the fatigue scores in IBD patients in deep clinical and biological remission.

NCT ID: NCT03518814 Completed - Remission Clinical Trials

Quality of Life in Patients With Multimetastatic Melanoma Currently in Remission (QUALM)

QUALM
Start date: April 9, 2018
Phase:
Study type: Observational

Few studies have been conducted on the quality of life of patients with stage IV melanoma. Particularly, there is no data regarding the quality of life of patients with a multimetastatic melanoma currently in remission. Then, the main objective of this study is to evaluate the quality of life from a point of view medico-psycho-social in patients with multimetastatic melanoma in remission for more than 6 months.

NCT ID: NCT03123640 Completed - Clinical trials for Drug-Related Side Effects and Adverse Reactions

Improving Drug Safety in Emergency Patients -a Randomized Controlled Trial

EPIMERR
Start date: April 24, 2017
Phase: N/A
Study type: Interventional

Aim/Objective: Investigate the effect of implementing a working model for performing medication reconciliation (MR) and medication review (MRe) in the emergency department (ED), on readmissions, patient safety and efficiency of the stay in the ED and the hospital. Research design: randomized, controlled, non-blinded trial. Control group; standard care. Intervention group; MR and MRe performed at admission to the ED by a clinical pharmacist in the interdisciplinary team. The intervention is based on a working model for MR, developed in our initiation project, and it will be adapted to also include MRe. Key challenges in this research field: Currently no implemented systematic model ensuring that the patient's correct medication list is obtained and assessed at the point of admission. There is lack of studies investigating the clinically outcome of performing MR and MRe in the ED. Lack of knowledge on the extent of drug related hospital admissions in Norway. These challenges are also recognized and prioritized by the Norwegian authorities. Impact and utility: The results from this study will give important answers to the challenges listed above. The results could imply a huge impact on how to organize ED in Norway regarding drug safety. If the hypothesis of this study is confirmed, implementing the intervention described will increase patient safety, both the hospital and society can reduce health care expenses from readmissions, and also the readmission-burden can be reduced for the patients.